The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Induced Pluripotent Stem Cells from Patients with Huntington's Disease Show CAG-Repeat-Expansion-Associated Phenotypes
Open accessAbstract
Huntington's disease (HD) is an inherited neurodegenerative disorder caused by an expanded stretch of CAG trinucleotide repeats that results in neuronal dysfunction and death. Here, the HD consortium reports the generation and characterization of 14 induced pluripotent stem cell (iPSC) lines from HD patients and controls. Microarray profiling revealed CAG expansion-associated gene expression patterns that distinguish patient lines from controls, and early onset versus late onset HD. Differentiated HD neural cells showed disease associated changes in electrophysiology, metabolism, cell adhesion, and ultimately cell death for lines with both medium and longer CAG repeat expansions. The longer repeat lines were however the most vulnerable to cellular stressors and BDNF withdrawal using a range of assays across consortium laboratories. The HD iPSC collection represents a unique and well-characterized resource to elucidate disease mechanisms in HD and provides a novel human stem cell platform for screening new candidate therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Protein aggregation and neurodegenerative disease
Ross, C. A., & Poirier, M. A. (2004) · Nature Medicine · doi:10.1038/nm1066 · Cited by 3,454
Adams, J. L., Dinesh, K., Xiong, M., Tarolli, C. G., Sharma, S., Sheth, N., Aranyosi, A. J., Zhu, W., Goldenthal, S., Biglan, K. M., et al. (2017) · Digital Biomarkers · doi:10.1159/000479018 · Cited by 3,171
Walker, F. O. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60111-1 · Cited by 2,603
Human induced pluripotent stem cells free of vector and transgene sequences
Yu, J., Hu, K., Smuga-Otto, K., Tian, S., Stewart, R., Slukvin, I. I., & Thomson, J. A. (2009) · Science · doi:10.1126/science.1172482 · Cited by 2,386
Disease-Specific Induced Pluripotent Stem Cells.
Park, I.-H., Arora, N., Huo, H., Maherali, N., Ahfeldt, T., Shimamura, A., Lensch, M. W., Cowan, C., Hochedlinger, K., & Daley, G. Q. (2008) · Cell · doi:10.1016/j.cell.2008.07.041 · Cited by 2,196 · cited 1×
“Indeed, human iPSC lines have been generated from a variety of individuals, including HD patients (Park et al., 2008).”
BackgroundInclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death
Arrasate, M., Mitra, S., Schweitzer, E. S., Segal, M. R., & Finkbeiner, S. (2004) · Nature · doi:10.1038/nature02998 · Cited by 1,979
Huntington's disease: from molecular pathogenesis to clinical treatment
Ross, C. A., & Tabrizi, S. J. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70245-3 · Cited by 1,743
Induced pluripotent stem cells from a spinal muscular atrophy patient
Ebert, A. D., Yu, J., Rose, F. F., Mattis, V. B., Lorson, C. L., Thomson, J. A., & Svendsen, C. N. (2009) · Nature · doi:10.1038/nature07677 · Cited by 1,441
Brain-derived neurotrophic factor in neurodegenerative diseases
Zuccato, C., & Cattaneo, E. (2009) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.54 · Cited by 947
Molecular Mechanisms and Potential Therapeutical Targets in Huntington's Disease
Zuccato, C., Valenza, M., & Cattaneo, E. (2010) · Physiological Reviews · doi:10.1152/physrev.00041.2009 · Cited by 848
Regional and cellular gene expression changes in human Huntington's disease brain
Hodges, A., Strand, A. D., Aragaki, A. K., Kuhn, A., Sengstag, T., Hughes, G., Elliston, L. A., Hartog, C., Goldstein, D. R., Thu, D., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl013 · Cited by 804
LRRK2 Mutant iPSC-Derived DA Neurons Demonstrate Increased Susceptibility to Oxidative Stress
Nguyen, H. N., Byers, B., Cord, B., Shcheglovitov, A., Byrne, J., Gujar, P., Kee, K., Schüle, B., Dolmetsch, R. E., Langston, W., et al. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2011.01.013 · Cited by 745
Decreased expression of striatal signaling genes in a mouse model of Huntington's disease
Luthi-Carter, R. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.9.1259 · Cited by 720
A new method for the rapid and long term growth of human neural precursor cells
Svendsen, C. N., ter Borg, M. G., Armstrong, R. J. E., Rosser, A. E., Chandran, S., Ostenfeld, T., & Caldwell, M. A. (1998) · Journal of Neuroscience Methods · doi:10.1016/s0165-0270(98)00126-5 · Cited by 572
p53 Mediates Cellular Dysfunction and Behavioral Abnormalities in Huntington’s Disease
Bae, B.-I., Xu, H., Igarashi, S., Fujimuro, M., Agrawal, N., Taya, Y., Hayward, S. D., Moran, T. H., Montell, C., Ross, C. A., et al. (2005) · Neuron · doi:10.1016/j.neuron.2005.06.005 · Cited by 485
N-Methyl-d-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease
FAN, M., & RAYMOND, L. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.11.003 · Cited by 413
Seibler, P., Graziotto, J., Jeong, H., Simunovic, F., Klein, C., & Krainc, D. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.4441-10.2011 · Cited by 378
Faideau, M., Kim, J., Cormier, K., Gilmore, R., Welch, M., Auregan, G., Dufour, N., Guillermier, M., Brouillet, E., Hantraye, P., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq212 · Cited by 341
Langbehn, D. R., Hayden, M. R., Paulsen, J. S., & and the PREDICT‐HD Investigators of the Huntington Study Group (2010) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30992 · Cited by 338
Behrens, P. F. (2002) · Brain · doi:10.1093/brain/awf180 · Cited by 320
The Neuropathology of Huntington’s Disease
Waldvogel, H. J., Kim, E. H., Tippett, L. J., Vonsattel, J.-P. G., & Faull, R. L. (2014) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2014_354 · Cited by 317
Excitation-induced ataxin-3 aggregation in neurons from patients with Machado–Joseph disease
Koch, P., Breuer, P., Peitz, M., Jungverdorben, J., Kesavan, J., Poppe, D., Doerr, J., Ladewig, J., Mertens, J., Tüting, T., et al. (2011) · Nature · doi:10.1038/nature10671 · Cited by 303
HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism
Seong, I. S., Ivanova, E., Lee, J.-M., Choo, Y. S., Fossale, E., Anderson, M., Gusella, J. F., Laramie, J. M., Myers, R. H., Lesort, M., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi319 · Cited by 294
Aubry, L., Bugi, A., Lefort, N., Rousseau, F., Peschanski, M., & Perrier, A. L. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808488105 · Cited by 291
Characterization of Human Huntington's Disease Cell Model from Induced Pluripotent Stem Cells
Zhang, N., An, M. C., Montoro, D., & Ellerby, L. M. (2010) · PLoS Currents · doi:10.1371/currents.rrn1193 · Cited by 253
Stine, O. C., Pleasant, N., Franz, M. L., Abbott, M. H., Folstein, S. E., & Ross, C. A. (1993) · Human Molecular Genetics · doi:10.1093/hmg/2.10.1547 · Cited by 233
Pruunsild, P., Sepp, M., Orav, E., Koppel, I., & Timmusk, T. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.4540-10.2011 · Cited by 229
Shelbourne, P. F., Keller-McGandy, C., Bi, W. L., Yoon, S.-R., Dubeau, L., Veitch, N. J., Vonsattel, J. P., Wexler, N. S., Arnheim, N., & Augood, S. J. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm054 · Cited by 218
Miller, J. P., Holcomb, J., Al-Ramahi, I., de Haro, M., Gafni, J., Zhang, N., Kim, E., Sanhueza, M., Torcassi, C., Kwak, S., et al. (2010) · Neuron · doi:10.1016/j.neuron.2010.06.021 · Cited by 186
Camnasio, S., Carri, A. D., Lombardo, A., Grad, I., Mariotti, C., Castucci, A., Rozell, B., Riso, P. L., Castiglioni, V., Zuccato, C., et al. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.042 · Cited by 173
Cholesterol metabolism in Huntington disease
Karasinska, J. M., & Hayden, M. R. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.132 · Cited by 154
Age, CAG repeat length, and clinical progression in Huntington's disease
Rosenblatt, A., Kumar, B. V., Mo, A., Welsh, C. S., Margolis, R. L., & Ross, C. A. (2011) · Movement Disorders · doi:10.1002/mds.24024 · Cited by 126
Automated microscope system for determining factors that predict neuronal fate
Arrasate, M., & Finkbeiner, S. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409777102 · Cited by 126
Induced pluripotent stem cells: a new revolution for clinical neurology?
Mattis, V. B., & Svendsen, C. N. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70022-9 · Cited by 117
Molero, A. E., Gökhan, Ş., González, S. R., Feig, J. L., Alexandre, L. C., & Mehler, M. F. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912171106 · Cited by 113
Neuropathology of Huntington's Disease
Vonsattel, J. P., Keller, C. E., & Amaya, M. D. P. (2008) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)01256-0 · Cited by 107
Liévens, J.-C., Rival, T., Iché-Torres, M., Chneiweiss, H., & Birman, S. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi067 · Cited by 98
Important Role of Oxidative Stress Biomarkers in Huntington’s Disease
Túnez, I., Sánchez‐López, F., Agüera, E., Fernández‐Bolaños, R., Sánchez, F. M., & Tasset-Cuevas, I. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200605a · Cited by 93
CEP-1347 reduces mutant huntingtin-associated neurotoxicity and restores BDNF levels in R6/2 mice
Apostol, B. L., Simmons, D. A., Zuccato, C., Illes, K., Pallos, J., Casale, M., Conforti, P., Ramos, C., Roarke, M., Kathuria, S., et al. (2008) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2008.04.007 · Cited by 88
High mobility group box protein‐1 inhibits microglial Aβ clearance and enhances Aβ neurotoxicity
Takata, K., Kitamura, Y., Tsuchiya, D., Kawasaki, T., Taniguchi, T., & Shimohama, S. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20340 · Cited by 83
HD CAG-correlated gene expression changes support a simple dominant gain of function
Jacobsen, J. C., Gregory, G. C., Woda, J. M., Thompson, M. N., Coser, K. R., Murthy, V., Kohane, I. S., Gusella, J. F., Seong, I. S., MacDonald, M. E., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr195 · Cited by 73
Ginés, S., Paoletti, P., & Alberch, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.084202 · Cited by 72
Derivation of Huntington's Disease-Affected Human Embryonic Stem Cell Lines
Bradley, C. K., Scott, H. A., Chami, O., Peura, T., Dumevska, B., Schmidt, U., & Stojanov, T. (2011) · Stem Cells and Development · doi:10.1089/scd.2010.0120 · Cited by 72
Royer, B., Soares, D. C., Barlow, P. N., Bontrop, R. E., Roll, P., Robaglia‐Schlupp, A., Blancher, A., Levasseur, A., Cau, P., Pontarotti, P., et al. (2007) · BMC Genetics · doi:10.1186/1471-2156-8-72 · Cited by 67
A role for lipoprotein lipase during synaptic remodeling in the adult mouse brain
Blain, J., Paradis, E., Gaudreault, S. B., Champagne, D. L., Richard, D., & Poirier, J. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.12.001 · Cited by 41
Reis, S. A., Thompson, M. N., Lee, J., Fossale, E., Kim, H.-H., Liao, J. K., Moskowitz, M. A., Shaw, S. Y., Dong, L., Haggarty, S. J., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr127 · Cited by 39
Transcription meets metabolism in neurodegeneration
Ross, C. A., & Thompson, L. M. (2006) · Nature Medicine · doi:10.1038/nm1106-1239 · Cited by 31
Polymorphism of HD and UCHL-1 genes in Huntington’s disease
Xu, E., Tang, Y., Li, D., & Jia, J. (2009) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2009.03.027 · Cited by 19
Cited by
Bates, G. P., Dorsey, R., Gusella, J. F., Hayden, M. R., Kay, C., Leavitt, B. R., Nance, M., Ross, C. A., Scahill, R. I., Wetzel, R., et al. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.5 · Cited by 1,641
Targeting RNA Foci in iPSC-Derived Motor Neurons from ALS Patients with a C9ORF72 Repeat Expansion
Sareen, D., O’Rourke, J. G., Meera, P., Muhammad, A. K. M. G., Grant, S., Simpkinson, M., Bell, S., Carmona, S., Ornelas, L., Sahabian, A., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3007529 · Cited by 670
Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities
Tabrizi, S. J., Flower, M. D., Ross, C. A., & Wild, E. J. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0389-4 · Cited by 538
Guo, X., Disatnik, M.-H., Monbureau, M., Shamloo, M., Mochly-Rosen, D., & Qi, X. (2013) · Journal of Clinical Investigation · doi:10.1172/jci70911 · Cited by 370
Takata, K., Kozaki, T., Lee, C. Z. W., Thion, M. S., Otsuka, M., Lim, S., Utami, K. H., Fidan, K., Park, D. S., Malleret, B., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.06.017 · Cited by 351
Metadata
- Authors
- The HD iPSC Consortium
- Venue
- Cell Stem Cell
- Publisher
- Elsevier BV
- Published
- 2012-08
- Volume
- 11
- Issue
- 2
- Pages
- 264-278
- ISSN
- 1875-9777 (ISSN-L)
- 1934-5909
- OpenAlex
- W1497938915
- Cited by
- 490
- References
- 51
- FWCI
- 18.86
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.